Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-03-07
2006-03-07
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S213010, C514S217010, C514S221000, C540S552000, C540S569000, C540S593000, C540S594000, C540S595000
Reexamination Certificate
active
07008938
ABSTRACT:
A benzene-fused heteroring derivative of formula (I)wherein all symbols are the same as described in the specification, and a non-toxic salt thereof. The compound of formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of immune diseases (autoimmune diseases, infectious diseases, etc.), inflammatory diseases (inflammatory bowel diseases, multiple cerebrosclerosis, arthritis, etc.), nerve degeneration diseases (Alzheimer's disease, muscular dystrophy, etc.), bone resorption diseases (osteoporosis, etc.), respiratory system diseases, diabetes, shock, etc.
REFERENCES:
patent: 6410556 (2002-06-01), Anderson et al.
patent: 6797720 (2004-09-01), Ohmoto et al.
patent: 06-192199 (1994-07-01), None
Itagaki Iori
Ohmoto Kazuyuki
Nokia Corporation
O'Sullivan Peter
LandOfFree
Benzene-fused heteroring derivatives and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzene-fused heteroring derivatives and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzene-fused heteroring derivatives and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546815